Partner Content Partner Content 4th LNP Formulation & Process Development The 4th LNP Formulation & Process Development Summit is the largest forum dedicated to the end-to-end LNP Development
Partner Content Partner Content 6th TCR-based Therapies Summit Transforming Cell- & Biologic-based TCR Approaches
R&D Partner Content 2nd ADC Payload Summit Diversifying ADC Payloads as Warheads for Overcoming Tumor Resistance, With Optimized Efficacy, Potency, Mechanisms & Differentiated IP
R&D Partner Content 3rd Obesity & Weight Loss Summit The 3rd Obesity & Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling the obesity epidemic.
R&D Partner Content 6th Cytokine-Based Drug Development Summit 2025 With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t
R&D Partner Content 7th Neuroimmunology Drug Development Summit 7th Neuroimmunology Drug Development Summit | February 25-27 2025 | Boston, MA
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.